| Ugai et al.
4
|
C. canimorsus
|
Blood stream infection |
acute myeloid leukemia |
mismatched unrelated donor |
No |
7 years earlier HSCT |
Chronic GVHD, but no IST; marked splenic atrophy on CT history of licked wound by a dog 2 days before admission |
meropenem and vancomycin followed by ceftriaxone |
No data avaliable |
Discharged |
| García-Cía et al.
5
|
C. sputigena plus Escherichia coli |
Blood stream infection |
Hodgkin's lymphoma |
Autologous HSCT |
Yes |
D+2 |
Neutropenia |
amoxicillin/clavulanate followed by cefepime and amikacin |
No data avaliable |
Discharged |
| Bonatti et al.
6
|
C. ochraceae
|
Blood stream infection |
chronic myelogenous leukemia |
No data available |
Yes |
D+9 |
Neutropenia |
Cefandamole, amikazin vancomycin followed by Imipenem–cilastatin, PenG |
RAPID-ANA II System (Innovative Diagnostic Systems, Inc., Norcross, GA, USA); Restriction fragment length polymorphism (RFLP) |
Discharged |
| Bonatti et al.
6
|
C. ochraceae
|
Blood stream infection |
chronic myelogenous leukemia |
No data available |
Yes |
D+9 |
Neutropenia |
Cefamandole, tobramycin, vancomycin followed by Piperacillin–tazobactam |
RAPID-ANA II System (Innovative Diagnostic Systems, Inc., Norcross, GA, USA); Restriction fragment length polymorphism (RFLP) |
Discharged |
| Bonatti et al.
6
|
C. ochraceae
|
Blood stream infection |
acute myeloid leukemia |
No data available |
Yes |
D+6 |
Neutropenia |
Cefamandole, amikacin vancomycin followed by Imipenem–cilastatin |
RAPID-ANA II System (Innovative Diagnostic Systems, Inc., Norcross, GA, USA); Restriction fragment length polymorphism (RFLP) |
Discharged |
| Bonatti et al.
6
|
Capnocytophaga sp |
Blood stream infection |
chronic myelogenous leukemia |
No data available |
Yes |
D+8 |
Neutropenia |
Cefamandole followed by Imipenem–cilastatin |
RAPID-ANA II System (Innovative Diagnostic Systems, Inc., Norcross, GA, USA) |
Discharged |
| Geisler et al.
7
|
C. gingivalis
|
Pneumonia |
Acute myelogenous leukemia |
Autologous HSCT |
Yes |
No data avaliable |
Neutropenia |
Gentamicin and levofloxacin followed by linezolid and metronidazole |
Morphology and the following biochemical reactions |
Discharged |
| Bilgrami et al.
8
|
Capnocytophaga sp |
Blood stream infection |
Hodgkin's disease |
Autologous HSCT |
Yes |
D+3 |
Neutropenia |
Ceftazidime and clindamycin followed by ampicillin |
API AN-Ident System (Analytic Products, Plainview, NY) |
Discharged |
| Baquero et al.
9
|
C. ochraceae
|
Blood stream infection |
acute myeloid leukemia |
Autologous HSCT |
Yes |
D+2 |
Neutropenia |
Ceftazidime amikacin followed by piperacillin and subsequently clindamycin |
Morphology and the following biochemical reactions |
Discharged |
| This report |
Capnocytophaga sp |
Blood stream infection |
Hodgkin's lymphoma |
Autologous HSCT |
Yes |
D+5 |
Neutropenia |
Meropenem |
MALDI-TOF |
Discharged |
| This report |
Capnocytophaga sp |
Blood stream infection |
Peripheral T-cells NOS Lymphoma |
Autologous HSCT |
Yes |
D+10 |
Neutropenia |
Piperacillin tazobactam |
MALDI-TOF 16sRNA sequencing |
Discharged |